Top Markets
#1 Islamic Coin Islamic Coin +155.83%
#2 Siren Siren +35.99%
#3 Arowana Arowana +19.70%
#4 Nockchain Nockchain +17.28%
#5 The Grays Currency The Grays Currency +14.49%
#6 Cysic Cysic +13.46%
#7 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +13.37%
#8 Venom Venom +13.26%
#9 RedStone RedStone +13.22%
#10 KUB Coin KUB Coin +13.21%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Holista Colltech Limited Holista Colltech Limited

Holista Colltech Limited

HCT
Rank in Stocks #31670
Holista CollTech Limited is a biotechnology firm with operations spanning... Holista CollTech Limited is a biotechnology firm with operations spanning Australia, Malaysia, and the United States. Its business activities are organized into four key divisions: Supplements, Ovine Collagen, Infection Control Solutions, and Food Ingredients. The company specializes in the production and distribution of dietary supplements, cosmetic-quality collagen, and a variety of health-conscious food ingredients. These innovative food products include low-glycemic index (GI) flour blends suitable for noodles, pasta, flatbreads, and other baked goods, along with low-sodium salt, reduced-fat fried options, and both less-calorie and low-GI sugar alternatives. Furthermore, Holista CollTech offers solutions for infection control. Its corporate headquarters are located in Subiaco, Australia.
Share Price
$0.03385367
Market Cap
$12.45M
Change (1 day)
0.00%
Change (1 year)
-47.87%
Country
AU
Trade Holista Colltech Limited (HCT)

Category

Healthcare
Revenue for Holista Colltech Limited (HCT)
Revenue in Aug 2026 TTM: 0
According to Holista Colltech Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Holista Colltech Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR